BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24556643)

  • 1. Antiangiogenic therapy inhibits the recruitment of vascular accessory cells to the perivascular niche in glioma angiogenesis.
    Parmaksız G; Czabanka M; Vinci M; Vajkoczy P
    J Vasc Res; 2014; 51(2):102-9. PubMed ID: 24556643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F8-SIP mediated targeted photodynamic therapy leads to microvascular dysfunction and reduced glioma growth.
    Acker G; Palumbo A; Neri D; Vajkoczy P; Czabanka M
    J Neurooncol; 2016 Aug; 129(1):33-8. PubMed ID: 27188647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NDRG1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.
    Broggini T; Wüstner M; Harms C; Stange L; Blaes J; Thomé C; Harms U; Mueller S; Weiler M; Wick W; Vajkoczy P; Czabanka M
    Cancer Lett; 2016 Oct; 380(2):568-576. PubMed ID: 26297987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphB4 mediates resistance to antiangiogenic therapy in experimental glioma.
    Uhl C; Markel M; Broggini T; Nieminen M; Kremenetskaia I; Vajkoczy P; Czabanka M
    Angiogenesis; 2018 Nov; 21(4):873-881. PubMed ID: 29987450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors.
    Folkins C; Man S; Xu P; Shaked Y; Hicklin DJ; Kerbel RS
    Cancer Res; 2007 Apr; 67(8):3560-4. PubMed ID: 17440065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model.
    Valable S; Petit E; Roussel S; Marteau L; Toutain J; Divoux D; Sobrio F; Delamare J; Barré L; Bernaudin M
    Nucl Med Biol; 2011 Aug; 38(6):781-93. PubMed ID: 21843775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas.
    Farhadi MR; Capelle HH; Erber R; Ullrich A; Vajkoczy P
    J Neurosurg; 2005 Feb; 102(2):363-70. PubMed ID: 15739567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.
    Hatipoglu G; Hock SW; Weiss R; Fan Z; Sehm T; Ghoochani A; Buchfelder M; Savaskan NE; Eyüpoglu IY
    Cancer Sci; 2015 Feb; 106(2):160-70. PubMed ID: 25458015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells.
    Read TA; Farhadi M; Bjerkvig R; Olsen BR; Rokstad AM; Huszthy PC; Vajkoczy P
    Cancer Res; 2001 Sep; 61(18):6830-7. PubMed ID: 11559558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sunitinib on tumor hemodynamics and delivery of chemotherapy.
    Czabanka M; Vinci M; Heppner F; Ullrich A; Vajkoczy P
    Int J Cancer; 2009 Mar; 124(6):1293-300. PubMed ID: 19101989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC.
    Vajkoczy P; Menger MD; Goldbrunner R; Ge S; Fong TA; Vollmar B; Schilling L; Ullrich A; Hirth KP; Tonn JC; Schmiedek P; Rempel SA
    Int J Cancer; 2000 Jul; 87(2):261-8. PubMed ID: 10861485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined temozolomide and sunitinib treatment leads to better tumour control but increased vascular resistance in O6-methylguanine methyltransferase-methylated gliomas.
    Czabanka M; Bruenner J; Parmaksiz G; Broggini T; Topalovic M; Bayerl SH; Auf G; Kremenetskaia I; Nieminen M; Jabouille A; Mueller S; Harms U; Harms C; Koch A; Heppner FL; Vajkoczy P
    Eur J Cancer; 2013 Jun; 49(9):2243-52. PubMed ID: 23499430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging biomarker dynamics in an intracranial murine glioma study of radiation and antiangiogenic therapy.
    Chung C; Jalali S; Foltz W; Burrell K; Wildgoose P; Lindsay P; Graves C; Camphausen K; Milosevic M; Jaffray D; Zadeh G; Ménard C
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):805-12. PubMed ID: 22929856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects.
    Abdollahi A; Lipson KE; Sckell A; Zieher H; Klenke F; Poerschke D; Roth A; Han X; Krix M; Bischof M; Hahnfeldt P; Grone HJ; Debus J; Hlatky L; Huber PE
    Cancer Res; 2003 Dec; 63(24):8890-8. PubMed ID: 14695206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide.
    Zhou Q; Guo P; Gallo JM
    Clin Cancer Res; 2008 Mar; 14(5):1540-9. PubMed ID: 18316579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice.
    Barbieri F; Pattarozzi A; Gatti M; Aiello C; Quintero A; Lunardi G; Bajetto A; Ferrari A; Culler MD; Florio T
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1078-88. PubMed ID: 19706788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model.
    Zhou Q; Gallo JM
    Neuro Oncol; 2009 Jun; 11(3):301-10. PubMed ID: 18971416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescent diagnosis and photodynamic therapy for C6 glioma in combination with antiangiogenic therapy in subcutaneous and intracranial tumor models.
    Tzerkovsky DA; Osharin VV; Istomin YP; Alexandrova EN; Vozmitel MA
    Exp Oncol; 2014 Jun; 36(2):85-9. PubMed ID: 24980761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of the fibrinolytic system by cartilage extract mediates its antiangiogenic effect in mouse glioma.
    Simard B; Bouamrani A; Jourdes P; Pernod G; Dimitriadou V; Berger F
    Microvasc Res; 2011 Jul; 82(1):6-17. PubMed ID: 21406197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of glioma formation: iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy.
    Baker GJ; Yadav VN; Motsch S; Koschmann C; Calinescu AA; Mineharu Y; Camelo-Piragua SI; Orringer D; Bannykh S; Nichols WS; deCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
    Neoplasia; 2014 Jul; 16(7):543-61. PubMed ID: 25117977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.